Healthcare, Distribution, and Innovation by McKesson

  • Ashutosh Sureka
  • 2 hours ago
McKesson stock edges lower amid mixed technical momentum and overbought signals
McKesson says it works behind the scenes every day to keep medicines moving and support providers. The company states it is committed to strengthening access across communities.McKesson says ...
  • Jose Antonio Gastelum
  • 06.06.2026
McKesson stock gains 2.47 percent as company highlights InspiroGene support for expanding CGT programs
McKesson introduced InspiroGene to support treatment centers as more CGTs reach the market. The company announced this new offering amid growing complexity in therapy management.InspiroGene aims ...
  • Andreas Kristo
  • 05.06.2026
McKesson stock rises near weekly highs after strong intraday recovery
McKesson is working with state pharmacy associations through its McKesson Amplify platform to modernize member engagement and support community pharmacy.The company says McKesson Amplify helps ...
  • Ashutosh Sureka
  • 04.06.2026
Conference focus does not lift McKesson stock above resistance amid bearish technicals
McKesson led discussions at Asembia’s #AXS26 Summit, bringing industry leaders together to share practical perspectives on navigating complexity and advancing patient access.The event drew ...
  • Ciaran Ryan
  • 03.06.2026
McKesson stock consolidates below key averages as price remains under $755 resistance
McKesson says it is focused on connecting patients to cutting-edge cancer therapies closer to home.McKesson states it has long believed the future of cancer care lies in the community. The company ...
  • Hanna Syniavska
  • 26.03.2026
McKesson stock price forecast: oversold reading as MCK eyes rebound from key support
McKesson reports that clinical trials in the community setting are accelerating innovation and broadening hope for patients.David Spigel, MD, president and CMO at Sarah Cannon, addresses how ...
  • Ashutosh Sureka
  • 23.03.2026
McKesson stock price forecast for 2040: Oncology network and earnings growth drive $2,500 outlook
​McKesson Corporation (MCK) is trading near $885.84, a long way from the $999 high it reached not too long ago, and the speed of that drop has been notable. The company moves roughly one-third ...
  • Olesia Kramarenko
  • 20.03.2026
McKesson Corporation opens registration for ideaShare 2026 to unite pharmacy professionals
McKesson Corporation has officially opened registration for ideaShare 2026, its leading annual event for pharmacy professionals across the U.S. The initiative aims to strengthen the independent ...
  • Anastasiia Chabaniuk
  • 11.03.2026
Amplify provides funding boost to state pharmacy associations, McKesson Corporation asserts
McKesson Corporation has introduced the Amplify initiative, aiming to empower independent pharmacies by providing funding to eligible state pharmacy associations. The company states that this ...
  • Olesia Kramarenko
  • 06.03.2026
McKesson Corporation drives patient access with new cell and gene therapy support model
McKesson Corporation is advancing patient care by implementing a support model tailored to the complexities of cell and gene therapies. According to McKesson experts featured in Pharma Commerce, ...
  • Ashutosh Sureka
  • 06.02.2026
McKesson Corporation: Margaret Buckley drives cancer care impact
At the McKesson Foundation, leadership is personal for Margaret Buckley, whose connection to cancer guides her initiatives. Buckley is instrumental in reducing the burden on patients and ...
  • Dmytro Kharkov
  • 03.12.2025
McKesson Corporation pushes for biopharma collaboration in cancer care
McKesson Corporation is emphasizing the importance of collaboration in reshaping cancer care due to rapid policy changes. The company highlights the need for biopharma companies to partner with ...
  • Andreas Kristo
  • 29.10.2025
McKesson Corporation drives strategy discussions at CEO CFO Roundtable
McKesson Corporation will participate in Becker's 13th Annual CEO + CFO Roundtable in Chicago. They aim to foster strategic discussions on leveraging ambulatory pharmacy settings. Taking place ...
  • Yulia Slavina
  • 28.10.2025
McKesson Corporation expands genomic testing access through consortium
McKesson Corporation, a leader in healthcare services and product distribution, is spearheading efforts to broaden the reach of genomic testing and targeted therapies through its Precision Care ...